Holen Sie sich die Stockscreener-App
20.16
4.32%
-0.91
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$21.07
Offen:
$20.83
24-Stunden-Volumen:
1.35M
Relative Volume:
0.72
Marktkapitalisierung:
$1.37B
Einnahmen:
$796.00M
Nettoeinkommen (Verlust:
$-136.49M
KGV:
-9.6459
EPS:
-2.09
Netto-Cashflow:
$-64.24M
1W Leistung:
-7.10%
1M Leistung:
-10.80%
6M Leistung:
+28.00%
1J Leistung:
-46.28%
1-Tages-Spanne:
$20.11
$21.98
1-Wochen-Bereich:
$20.11
$22.14
52-Wochen-Spanne:
$9.98
$37.93
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Vergleichen Sie TNDM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
20.16 | 1.43B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | Fortgesetzt | Stifel | Hold |
| 2025-09-08 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-06-16 | Eingeleitet | Truist | Hold |
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2025-03-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Diabetes warning issued over insulin pump error - MSN
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - morningstar.com
Aug Ideas: Can Tandem Diabetes Care Inc continue delivering strong returnsDollar Strength & High Win Rate Trade Alerts - baoquankhu1.vn
Behavioral Patterns of TNDM and Institutional Flows - Stock Traders Daily
A Look At The Fair Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - 富途牛牛
Stock Analysis: How Tandem Diabetes Care Inc stock responds to policy changesDip Buying & Daily Entry Point Alerts - Bộ Nội Vụ
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a Path with a 20% Upside Potential - DirectorsTalk Interviews
Retail Surge: Whats the beta of Tandem Diabetes Care Inc stockQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Tandem Diabetes and Roche Reach a Patent Settlement - MSN
Published on: 2026-01-12 19:30:56 - Улправда
Insulin Patch Pump Market Is Going to Boom | Medtronic • Insulet Corporation • Tandem Diabetes Care - openPR.com
Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued? - Yahoo Finance
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates - MSN
Tandem Diabetes Care updates bylaws, tightens governance rules - MSN
TNDM: Tandem Diabetes Care Receives Updated Market Perform Ratin - GuruFocus
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 6.9%What's Next? - MarketBeat
Market Outlook: Will Tandem Diabetes Care Inc. stock outperform value stocksJuly 2025 Update & Weekly Breakout Stock Alerts - ulpravda.ru
Will Tandem Diabetes Care Inc. stock gain from strong economyQuarterly Earnings Summary & Consistent Profit Trading Strategies - Улправда
Will Tandem Diabetes Care Inc. stock benefit from green energy trends2025 Top Gainers & Community Supported Trade Ideas - ulpravda.ru
Will Tandem Diabetes Care Inc. stock outperform value stocksJuly 2025 Update & Weekly Breakout Stock Alerts - ulpravda.ru
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 - Chartmill
Market Catalysts: Will Tandem Diabetes Care Inc. stock benefit from green energy trendsJuly 2025 Momentum & Free Long-Term Investment Growth Plans - ulpravda.ru
How interest rate cuts could boost Tandem Diabetes Care Inc. stockJuly 2025 Patterns & Daily Entry Point Alerts - ulpravda.ru
How resilient is Tandem Diabetes Care Inc. stock in market downturnsGap Down & Weekly Sector Rotation Insights - Улправда
Published on: 2026-01-08 20:49:56 - ulpravda.ru
Published on: 2026-01-08 20:49:15 - ulpravda.ru
Tandem Diabetes Care Targets Longer-Wear Infusion Sets in New Home-Use Study - TipRanks
Is Tandem Diabetes Care Inc. (TD5A) stock supported by free cash flowQuarterly Trade Summary & AI Enhanced Execution Alerts - ulpravda.ru
Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - MSN
What risks investors should watch in Tandem Diabetes Care Inc. stockEconomic Indicators Overview & Budget Friendly Portfolio Growth - ulpravda.ru
Will Tandem Diabetes Care Inc. stock benefit from infrastructure spendingFlag and Pennant Patterns & Low Cost Capital Trading - ulpravda.ru
Tandem Diabetes Care (NASDAQ:TNDM) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Why Tandem Diabetes Care Inc. (TD5A) stock is a strong analyst pick2026 world cup usa national team qualification defensive leaders pressing system knockout prediction breakdown - ulpravda.ru
Positive changes ahead for diabetes in 2026 - BioWorld MedTech
Reasons to hold Tandem Diabetes stock in your portfolio for now - MSN
Tandem Diabetes Care (FRA:TD5A) EV-to-OCF : -178.93 (As of Jan. 03, 2026) - GuruFocus
The End of Shots? 5 Biotech Stocks Rethinking Diabetes - The Globe and Mail
Disposable Insulin Pumps Market is expected to reach US$ 6.9 - openPR.com
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Assessing Future Growth in the Medical Devices Sector - DirectorsTalk Interviews
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors t - GuruFocus
Tandem Diabetes Care Updates Bylaws, Tightens Governance Rules - TipRanks
Paradice Investment Management LLC Has $26.67 Million Stock Holdings in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - ACCESS Newswire
Favourable Signals For Tandem Diabetes Care: Numerous Insiders Acquired Stock - 富途牛牛
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE - GlobeNewswire Inc.
HEDIS Glycemic Goal Achieved Using Control-IQ Technology - The American Journal of Managed Care® (AJMC®)
Is Tandem Diabetes Care (TNDM) Still Undervalued After Its Recent Share Price Rebound? - Yahoo Finance
What Tandem Diabetes Care (TNDM)'s Canadian Smartphone Bolus Launch Means For Shareholders - Yahoo Finance
Tandem Diabetes Care (FRA:TD5A) EV-to-OCF : -179.84 (As of Dec. 25, 2025) - GuruFocus
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tandem Diabetes Care Inc-Aktie (TNDM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Carpenter Rick | Chief Technology Officer |
Dec 15 '25 |
Option Exercise |
0.00 |
406 |
0 |
24,459 |
| Morrison Susan | EVP & Chief Admin. Officer |
Nov 17 '25 |
Option Exercise |
0.00 |
2,599 |
0 |
41,231 |
| Sheridan John F | PRESIDENT & CEO |
Nov 17 '25 |
Option Exercise |
0.00 |
11,454 |
0 |
120,638 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Nov 17 '25 |
Option Exercise |
0.00 |
2,599 |
0 |
3,587 |
| Carpenter Rick | Chief Technology Officer |
Nov 17 '25 |
Option Exercise |
0.00 |
2,334 |
0 |
24,509 |
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Nov 17 '25 |
Option Exercise |
0.00 |
76 |
0 |
32,424 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Nov 17 '25 |
Option Exercise |
0.00 |
2,999 |
0 |
38,184 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Nov 17 '25 |
Option Exercise |
0.00 |
3,063 |
0 |
21,867 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Oct 15 '25 |
Option Exercise |
0.00 |
3,636 |
0 |
23,685 |
| Carpenter Rick | Chief Technology Officer |
Sep 15 '25 |
Option Exercise |
0.00 |
406 |
0 |
22,773 |
0.42%
1.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):